Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathway Data Analysis Platform to Exelixis

NEW YORK , May 13 (GenomeWeb News) — GeneGo has licensed its MetaCore pathway analysis and datamining platform to Exelixis, the St. Joseph, Mich. -based company said today.

 

MetaCore allows researcher to mine high-throughput experimental data in the context of biological networks, pathways, and human diseases.

 

Earlier this week , GeneGo licensed its MetaCore and MetaBase products to Procter & Gamble Pharmaceuticals.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.